21.83 -0.12 (-0.55%)
ECT
| Trade ECT now with |
|
Stock Details
Last Trade:21.83 Change:-0.12 (-0.55%) Prev Close:21.95 Open: 21.97 Days Range:21.71 – 22.23 52 Week Range: 19.16 - 32.92 Volume:33053 P/E: N/AEPS:0.00
View AllRecent Alerts 02/10/12
Recent Alert on 01/09/12 at 11:16am
Morning Movers 01/09: (INHX) (IDIX) (SMSI) (CVV) (VVUS) Higher; (THRX) (IPCM) (PWRD) (ATX) Lower
Morning Movers 01/09: (INHX) (IDIX) (SMSI) (CVV) (VVUS) Higher; (THRX) (IPCM) (PWRD) (ATX) Lower
Inhibitex, Inc. (Nasdaq: INHX) 141% HIGHER; Bristol-Myers Squibb Company (NYSE: BMY) announced a definitive agreement to acquire Inhibitex for $26.00 per share in cash, or approximately $2.5 billion. Idenix Pharma (Nasdaq: IDIX) 34.8% HIGHER;... Read More
Recent Alert on 01/09/12 at 9:28am
Pre-Open Movers 1/9 (INHX) (IDIX) (AAPL) Higher; (IPCM) (SPRD) (AFL) Lower (mroe...)
Pre-Open Movers 1/9 (INHX) (IDIX) (AAPL) Higher; (IPCM) (SPRD) (AFL) Lower (mroe...)
Recent Alert on 01/09/12 at 7:51am
Oppenheimer Downgrades ECA Marcellus Trust (ECT) to Underperform, Sees 24% Downside
Oppenheimer Downgrades ECA Marcellus Trust (ECT) to Underperform, Sees 24% Downside
Recent Alert on 01/09/12 at 7:51am
Oppenheimer Downgrades ECA Marcellus Trust (ECT) to Underperform, Sees 24% Downside
Oppenheimer Downgrades ECA Marcellus Trust (ECT) to Underperform, Sees 24% Downside